New HPLC assay for urinary salbutamol concentrations in samples collected post-inhalation
Authors:
- H. ChrystynHCH. Chrystyn
- 1 September 2009
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 50 (2) , 175-182
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Relative bioavailability of salbutamol to the lung following inhalation when administration is prolonged2000
- Methods to determine lung distribution of inhaled drugs – could gamma scintigraphy be the gold standard?British Journal of Clinical Pharmacology, 2000
- Enantiomeric disposition of inhaled, intravenous and oral racemic‐salbutamol in man — no evidence of enantioselective lung metabolismBritish Journal of Clinical Pharmacology, 2000
- Relative bioavailability of salbutamol to the lung following inhalation via a novel dry powder inhaler and a standard metered dose inhalerBritish Journal of Clinical Pharmacology, 1997
- Validation of high-performance liquid chromatographic methods on two silica base-deactivated reversed phases for the determination of chloroprocaine and bupivacaineJournal of Pharmaceutical and Biomedical Analysis, 1996
- Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamolBritish Journal of Clinical Pharmacology, 1996
- Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.Thorax, 1993
- Clinical Pharmacokinetics of ??-AgonistsClinical Pharmacokinetics, 1990
- Method validation in the bioanalytical laboratoryJournal of Pharmaceutical and Biomedical Analysis, 1990
- Evaluation of criteria for the acceptance of bioanalytical dataJournal of Pharmaceutical and Biomedical Analysis, 1990